Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 10/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | PPARG | P37231 | 1/20 | 0.53 |
| ▸ | NCOA2 | Q15596 | 1/20 | 0.53 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.53 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6604582 | 0.87 | PTGDR2 (0.60) | PTGDR2KDM4EPOLBL3MBTL1TRPM8 | |
| SCHEMBL18015850 | 0.84 | L3MBTL1 (0.55) | PTGDR2KDM4EPOLBL3MBTL1ALDH1A1 | |
| SCHEMBL4479582 | 0.84 | PPARD (0.56) | PTGDR2KDM4EALDH1A1PPARG | |
| SCHEMBL6603517 | 0.83 | L3MBTL1 (0.58) | PTGDR2KDM4EPOLBL3MBTL1ALDH1A1 | |
| SCHEMBL3537226 | 0.81 | PTGDR2 (0.56) | PTGDR2KDM4EPOLBALDH1A1PPARG | |
| SCHEMBL6603353 | 0.80 | L3MBTL1 (0.52) | PTGDR2KDM4EPOLBL3MBTL1ALDH1A1 | |
| SCHEMBL20397388 | 0.78 | PTGDR2 (0.69) | PTGDR2KDM4EPOLBALDH1A1PPARG | |
| SCHEMBL6602729 | 0.78 | L3MBTL1 (0.74) | PTGDR2KDM4EPOLBL3MBTL1ALDH1A1 | |
| SCHEMBL9555418 | 0.78 | PTGDR2 (0.60) | PTGDR2KDM4EPOLBALDH1A1PPARG | |
| SCHEMBL9555272 | 0.78 | PTGDR2 (0.56) | PTGDR2KDM4EPOLBALDH1A1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1102757-B1 | SUBSTITUTED OXAZOLE AND THIAZOLE DERIVATIVES AS HPPAR GAMMA AND HPPAR ALPHA ACTIVATORS | GLAXO GROUP LTD (GB) | 2004-04-14 | — | — | EP | disclosed |
| US-6498174-B1 | AGONISTS TO PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; MODULATING BLOOD GLUCOSE AND LIPID LEVELS; REDUCING DYSLIPIDEMIA AND HYPERINSULINEMIA ASSOCIATED WITH IMPAIRED GLUCOSE TOLERANCE OR METABOLIC SYNDROME | SMITHKLINE BEECHAM CORPORATION | 2002-12-24 | — | — | US | disclosed |
| EP-1102757-A1 | SUBSTITUTED OXAZOLE AND THIAZOLE DERIVATIVES AS HPPAR GAMMA AND HPPAR ALPHA ACTIVATORS | GLAXO GROUP LIMITED (GB) | 2001-05-30 | — | — | EP | disclosed |
| WO-2000008002-A1 | SUBSTITUTED OXAZOLES AND THIAZOLES DERIVATIVES AS hPPAR GAMMA AND hPPAR ALPHA ACTIVATORS | GLAXO GROUP LIMITED (GB) | 2000-02-17 | — | — | WO | disclosed |